News
FDA approves Ajovy for migraine prevention
The injection is available in a 225-mg dose monthly or a 675-mg dose every 3 months.
News
CDC opens Emergency Operations Center in advance of Hurricane Florence
Activation of the center will allow for 24/7 management of all CDC activities before, during, and after the hurricane’s landfall, including...
News
Female to male transgender teens most likely to attempt suicide
Identifying as heterosexual identifying as non-heterosexual was associated with an increased risk of attempting suicide, except in nonbinary...
News
Antidepressants not effective in treating depression in patients with dementia
Compared with placebo, antidepressants were associated with a higher remission rate and more adverse events.
News
FDA approves first mobile app for contraceptive use
The app uses an algorithm that calculates days of the month women are likely to be fertile, based on daily body temperature readings and menstrual...
News
Parents’ religiosity tied to reduced suicide risk in girls
Girls with parents who considered religion important in their lives were less likely to consider or attempt suicide.
News
Clinical trial: Robotic versus laparoscopic ventral hernia repair
Evidence of the outcomes from robotic approaches to hernia repair is being collected and evaluated.
News
Generic versions of Suboxone approved for opioid dependence
The FDA says patients who receive medication-assisted treatment for opioid use disorder reduce their risk of death from all causes by 50%.
News
Benefits of nicotine preloading undercut by reduced varenicline usage
A study looked at the impact on smoking cessation of a prequit nicotine patch.
News
Most U.S. buprenorphine prescribers assess patients for diversion
More than 80% of prescribers are willing to terminate treatment because of diversion concerns, survey shows.
News
CDC warns of hepatitis A outbreaks in injection drug users
Gap in vaccine availability now has been solved.
News
FDA approves Prolia for glucocorticoid-induced osteoporosis
The approval is based on superiority over risedronate in a phase 3 trial.
News
FDA approves Aimovig for migraine prevention
Aimovig is the first FDA-approved treatment to prevent migraines by blocking the calcitonin gene–related peptide receptor.
News
Certolizumab pegol shows promise for nr-axSpA treatment
C-AXSPAND is the first year-long trial to show positive results vs. placebo in nonradiographic axial spondyloarthritis.
News
Parents smoke less tobacco, more cannabis at home
Secondhand tobacco smoke exposure in childhood is decreasing, while cannabis smoke exposure rises.